Inventor · King of Prussia, PA, US

Daniel McGarry

45Patents
15h-index
71Co-inventors
84Inventor score

Filing activity: Feb 5, 1991 → Sep 27, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US6800645B1 Substituted azabicyclic compounds Chemistry; Metallurgy 68 Expired
US7005440B1 Therapeutic uses of tri-aryl acid derivatives Chemistry; Metallurgy 54 Expired
US9511142B2 Beta-lactamase inhibitors Emerging Cross-Sectional Technologies 46 Active
US6323227A Substituted N-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides Chemistry; Metallurgy 42 Expired
US6635655B1 Therapeutic uses of di-aryl acid derivatives Chemistry; Metallurgy 36 Expired
US5571506A Aromatic oligomeric compounds useful as mimics of bioactive macromolecules Chemistry; Metallurgy 35 Expired
US8912169B2 Beta-lactamase inhibitors Emerging Cross-Sectional Technologies 30 Active
US6303600A Substituted azabicyclic compounds Chemistry; Metallurgy 29 Expired
US9040504B2 Beta-lactamase inhibitors Emerging Cross-Sectional Technologies 28 Active
US7329675B2 Substituted azabicyclic compounds Chemistry; Metallurgy 25 Expired
US7326792B2 Heterocyclic compounds as P2X7 ion channel blockers Chemistry; Metallurgy 25 Expired
US9403850B2 Beta-lactamase inhibitors Emerging Cross-Sectional Technologies 22 Active
US9376454B2 Beta-lactamase inhibitors Emerging Cross-Sectional Technologies 21 Active
US9422314B2 Beta-lactamase inhibitors Emerging Cross-Sectional Technologies 21 Active
US9637504B2 Beta-lactamase inhibitors Human Necessities 17 Active
US9828391B2 Beta-lactamase inhibitors Emerging Cross-Sectional Technologies 13 Active
US9771382B2 Beta-lactamase inhibitors Emerging Cross-Sectional Technologies 13 Active
US9783555B2 Beta-lactamase inhibitors Human Necessities 12 Active
US6034093A Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds Chemistry; Metallurgy 12 Expired
US9802966B2 Beta-lactamase inhibitors Emerging Cross-Sectional Technologies 9 Active
US9926336B2 Beta-lactamase inhibitors Human Necessities 9 Active
US9944658B2 Beta-lactamase inhibitors Emerging Cross-Sectional Technologies 9 Active
US10214547B2 Beta-lactamase inhibitors Emerging Cross-Sectional Technologies 8 Active
US5731315A Substituted sulfonic acid n-(aminoiminomethyl)phenylalkyl!-azaheterocyclamide compounds Chemistry; Metallurgy 8 Expired
USRE40558E1 Therapeutic uses of di-aryl acid derivatives General 8 Expired

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.